Detalles de la búsqueda
1.
Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16.
Euro Surveill
; 22(18)2017 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28494843
2.
Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years.
Hum Vaccin
; 7(10): 1060-5, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21941091
3.
Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age.
Hum Vaccin
; 7(5): 549-56, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21441781
4.
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series.
Vaccine
; 38(35): 5718-5725, 2020 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654902
5.
Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.
J Urol
; 181(4): 1571-80, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19230924
6.
A reliable diagnosis of human rabies based on analysis of skin biopsy specimens.
Clin Infect Dis
; 47(11): 1410-7, 2008 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18937576
7.
Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
Vaccine
; 35(30): 3764-3772, 2017 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28583305
8.
The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children.
Vaccine
; 34(35): 4221-4228, 2016 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27364096
9.
Diphtheria, tetanus and poliovirus antibody persistence 5 years after vaccination of pre-schoolers with two different diphtheria, tetanus and inactivated poliomyelitis vaccines (Td-IPV or DT-IPV) and immune responses to a booster dose of DTaP-IPV.
Vaccine
; 33(32): 3988-96, 2015 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-26087294
10.
Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
Vaccine
; 33(6): 789-95, 2015 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25555381
11.
Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: a randomized study of a single dose vs. two different two-dose schedules.
Hum Vaccin Immunother
; 9(4): 858-64, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23319176
12.
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries.
Hum Vaccin Immunother
; 8(12): 1875-81, 2012 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23032160
13.
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial.
Vaccine
; 27(8): 1184-91, 2009 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-19135496
14.
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers.
Vaccine
; 26(7): 978-87, 2008 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-18207287
Resultados
1 -
14
de 14
1
Próxima >
>>